Today: 9 June 2026
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy
9 June 2026
2 mins read

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

New York, June 9, 2026, 08:07 EDT

  • Factorial Energy’s Class A shares started trading on Nasdaq under the ticker FAC on June 8 after CGCT switched over. Warrants now trade as FACWW and units were suspended.
  • FAC jumped 16% to $13.80 at Monday’s close. Early Tuesday, premarket quotes had it near $20.70 ahead of the Nasdaq open.
  • The transaction puts the equity value at roughly $1.3 billion and raised over $100 million in gross proceeds to support battery commercialization.

Factorial Energy Inc. saw new premarket demand on Tuesday, building on a strong first day of trading with the FAC ticker after swapping in for Cartesian Growth Corporation III on Nasdaq. Shares closed the opening session with a big gain.

CGCT isn’t just a SPAC anymore. The company has shed its status as a blank-check shell after the merger. A SPAC—short for special purpose acquisition company—is a listed cash shell that combines with a private firm. Now the ticker links to an operating battery company, not just cash.

Nasdaq said Cartesian Growth Class A shares have converted to Factorial Energy Class A common stock under the ticker FAC. The CGCTW warrants are now trading as FACWW. The move follows the close of the business combination on June 5 and took effect June 8.

No regular trading yet at the dateline. Nasdaq is set to open its U.S. session at 9:30 a.m. Eastern and run through 4 p.m., after premarket hours from 4 a.m. to 9:30 a.m. June 9 will not be a market holiday in 2026, according to Nasdaq.

Factorial said the deal brings in capital to move ahead with next-gen batteries in defense, aerospace, hyperscale data centers, and e-mobility. A PIPE is privately placed stock that a public company sells. Peter Yu, chairman and CEO of Cartesian Growth III, said his group was “proud to anchor the common-equity PIPE.” GlobeNewswire

Factorial CEO Siyu Huang said, “We built Factorial to solve one of the hardest problems in energy.” He said the Nasdaq listing will help the company move faster. GlobeNewswire

Solid-state batteries have a solid electrolyte instead of the liquid found in standard lithium-ion cells. They’re expected to improve range, charging speeds and safety. The main hurdle now is showing the tech can actually scale—and that costs will line up with what carmakers or defense buyers want.

Factorial is focusing on validation milestones instead of large-scale output for now. The company pointed to Mercedes-Benz putting a modified EQS through a 1,205-kilometre single-charge run, Stellantis lab tests on 77 Ah cells, and recent deals to integrate batteries in drones across three continents.

Factorial joins a short list of battery-tech names trading publicly. QuantumScape, a solid-state rival, showed a market cap near $4.68 billion based on early quotes. Solid Power was around $642 million.

The deal setup helps account for some of the choppy trading in the stock. SEC filings showed investors pulled back 23,051,313 Cartesian Growth Class A ordinary shares before the domestication. Each CGCT Class A share left was reclassified one-for-one into Factorial Series A common stock.

The early jump isn’t all upside. Factorial is fresh on Nasdaq, still rolling out its tech, and the founders control voting with Series B shares, so it’s listed as a Nasdaq “controlled company.” Former Factorial holders are also looking at staggered lock-up expiries after the deal, with some unlocks linked to price targets. Factorial, Inc.

CGCT stockholders now see their old ordinary shares trading under the FAC ticker. Public warrants trade as FACWW. The next milestone is Nasdaq’s opening bell—Factorial said it will ring it June 17.

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock
Previous Story

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

AmpliTech’s 5G Radio Test Moves AMPG Shares
Next Story

AmpliTech’s 5G Radio Test Moves AMPG Shares

Go toTop